(BPT) - Werewolf Therapeutics' clinical trials are underway and they're already changing lives.

For one patient with metastatic cancer, a clinical trial has led to his life-changing breakthrough. This powerful moment has inspired the by Werewolf Therapeutics (NASDAQ: HOWL), a clinical-stage biopharmaceutical company pioneering a new class of conditionally activated cytokine therapies. The campaign aims to highlight Full Moon Moments in Werewolf clinical trials.

See Full Page